ELV insider filings
Elevance Health, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-20. Screen ELV transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 6 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing by 1 insider — 1,000 shares, $383,860 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 14 legs across 2 filings by 2 insiders — 11,884 shares, $5,230,357 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: sale of 2,343 shares @ $441.34 ($1,034,060) by Kaye Mark, filed 2026-10-23.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Kaye Mark — EVP & CFO | 2 | — | 13 legs · 10,584 sh · $4,658,357 | 2 |
| LAVU RATNAKAR — EVP & Chief Digital Info Ofr | 1 | — | 1 leg · 1,300 sh · $572,000 | — |
| PERU RAMIRO G — Director | 1 | 1 leg · 1,000 sh · $383,860 | — | — |
| Wessling Erin M — EVP & Chief Legal Officer | 1 | — | — | 2 |
| Craig Ryan R — EVP & Chief HR Officer | 1 | — | — | 1 |
Recent insider filings — Elevance Health, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-20 | 4 | PERU RAMIRO G — Director | Purchase (P): 1,000 @ $383.86 | EDGAR |
| 2026-11-06 | 4 | LAVU RATNAKAR — EVP & Chief Digital Info Ofr | Sale (S): 1,300 @ $440 | EDGAR |
| 2026-10-23 | 4 | Kaye Mark — EVP & CFO | Sale (S): 400 @ $434 · Sale (S): 321 @ $435.25 · Sale (S): 1,660 @ $436.20 · Sale (S): 560 @ $437.07 · Sale (S): 240 @ $438.22 · Sale (S): 1,160 @ $439.25 · +7 more | EDGAR |
| 2026-10-06 | 4 | Kaye Mark — EVP & CFO | Tax withholding (F): 4,161 @ $386.43 · Grant/award (A): 2,627 @ $0 | EDGAR |
| 2026-09-04 | 4 | Craig Ryan R — EVP & Chief HR Officer | Tax withholding (F): 144 @ $405.84 | EDGAR |
| 2026-09-04 | 4 | Wessling Erin M — EVP & Chief Legal Officer | Tax withholding (F): 94 @ $405.84 · Tax withholding (F): 255 @ $414.78 | EDGAR |
| 2026-07-17 | 4 | BOUDREAUX GAIL — President and CEO, Director | Purchase (P): 680 @ $366.41 · Purchase (P): 2,045 @ $368.25 | EDGAR |
| 2026-07-17 | 4 | PERU RAMIRO G — Director | Purchase (P): 1,000 @ $366.05 | EDGAR |
| 2026-06-15 | 4 | Penczek Ronald W — CAO & Controller | Sale (S): 369 @ $403.16 | EDGAR |
| 2026-06-12 | 4 | Dixon Robert L JR — Director | Sale (S): 151 @ $401.77 | EDGAR |
| 2026-05-20 | 4 | Penczek Ronald W — CAO & Controller | Option exercise (M): 654 @ $271.27 · Option exercise (M): 877 @ $311.48 · Sale (S): 1,531 @ $403.13 · Option exercise (M): 654 (derivative) @ $0 · Option exercise (M): 877 (derivative) @ $0 | EDGAR |
| 2026-05-15 | 4 | Jallal Bahija — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | Neri Antonio F — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | STRABLE-SOETHOUT DEANNA D — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | DeVore Susan D. — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | Dixon Robert L JR — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | SCHULMAN AMY W — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | Schneider Ryan M. — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | PERU RAMIRO G — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | COLLIS STEVEN H — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | HAY LEWIS III — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-03-23 | 4 | SCHULMAN AMY W — Director | Sale (S): 26 @ $287.50 | EDGAR |
| 2026-03-09 | 4 | Kendrick Charles Morgan JR — EVP & President, Commercial | Sale (S): 3,196 @ $284.92 | EDGAR |
| 2026-03-06 | 4 | COLLIS STEVEN H — Director | Purchase (P): 3,000 @ $289.84 | EDGAR |
| 2026-03-04 | 4 | Wessling Erin M — EVP & Chief Legal Officer | Grant/award (A): 2,976 @ $0 · Tax withholding (F): 417 @ $284.03 · Grant/award (A): 11,754 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Craig Ryan R — EVP & Chief HR Officer | Tax withholding (F): 25 @ $294.07 · Grant/award (A): 2,976 @ $0 · Tax withholding (F): 309 @ $284.03 · Grant/award (A): 11,754 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Kendrick Charles Morgan JR — EVP & President, Commercial | Tax withholding (F): 1,211 @ $294.07 · Grant/award (A): 4,017 @ $0 · Grant/award (A): 2,532 @ $0 · Tax withholding (F): 467 @ $284.03 · Grant/award (A): 15,870 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Kaye Mark — EVP & CFO | Tax withholding (F): 271 @ $294.07 · Grant/award (A): 6,377 @ $0 · Grant/award (A): 10,202 @ $0 · Tax withholding (F): 353 @ $284.03 · Grant/award (A): 25,188 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Norwood Felicia F — EVP &Chief Health Benefits Ofr | Tax withholding (F): 1,421 @ $294.07 · Grant/award (A): 5,951 @ $0 · Grant/award (A): 2,865 @ $0 · Tax withholding (F): 496 @ $284.03 · Grant/award (A): 23,512 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | LAVU RATNAKAR — EVP & Chief Digital Info Ofr | Tax withholding (F): 315 @ $294.07 · Grant/award (A): 5,101 @ $0 · Grant/award (A): 6,802 @ $0 · Tax withholding (F): 222 @ $284.03 · Grant/award (A): 20,152 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Penczek Ronald W — CAO & Controller | Tax withholding (F): 131 @ $294.07 · Grant/award (A): 426 @ $0 · Grant/award (A): 1,701 @ $0 · Grant/award (A): 266 @ $0 · Tax withholding (F): 37 @ $284.03 · Grant/award (A): 1,677 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Haytaian Peter D — EVP & Pres Carelon & CarelonRx | Tax withholding (F): 1,201 @ $294.07 · Grant/award (A): 2,865 @ $0 · Tax withholding (F): 446 @ $284.03 | EDGAR |
| 2026-03-04 | 4 | BOUDREAUX GAIL — President and CEO, Director | Tax withholding (F): 6,713 @ $294.07 · Grant/award (A): 16,153 @ $0 · Grant/award (A): 10,527 @ $0 · Tax withholding (F): 1,736 @ $284.03 · Grant/award (A): 63,818 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Craig Ryan R — EVP & Chief HR Officer | Tax withholding (F): 279 @ $341.83 | EDGAR |
| 2026-02-03 | 4 | SCHULMAN AMY W — Director | Grant/award (A): 218 @ $0 | EDGAR |
| 2025-10-03 | 4 | Kaye Mark — EVP & CFO | Tax withholding (F): 2,895 @ $340.24 | EDGAR |
| 2025-09-05 | 4 | Wessling Erin M — EVP & Chief Legal Officer | Tax withholding (F): 152 @ $321.59 | EDGAR |
| 2025-09-04 | 4 | Wessling Erin M — EVP & Chief Legal Officer | Grant/award (A): 931 @ $0 · Grant/award (A): 3,541 (derivative) @ $0 | EDGAR |
| 2025-09-04 | 4 | Craig Ryan R — EVP & Chief HR Officer | Grant/award (A): 970 @ $0 · Grant/award (A): 3,690 (derivative) @ $0 | EDGAR |
| 2025-08-21 | 4 | DeVore Susan D. — Director | Purchase (P): 1,200 @ $312.15 | EDGAR |
| 2025-08-05 | 4 | COLLIS STEVEN H — Director | Grant/award (A): 639 @ $0 | EDGAR |
| 2025-07-18 | 4 | BOUDREAUX GAIL — President and CEO, Director | Purchase (P): 2,334 @ $286.07 · Purchase (P): 5,116 @ $287.12 · Purchase (P): 1,050 @ $287.96 | EDGAR |
| 2025-05-16 | 4 | STRABLE-SOETHOUT DEANNA D — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-05-16 | 4 | Schneider Ryan M. — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-05-16 | 4 | PERU RAMIRO G — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-05-16 | 4 | Neri Antonio F — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-05-16 | 4 | Jallal Bahija — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-05-16 | 4 | HAY LEWIS III — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-05-16 | 4 | Dixon Robert L JR — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-05-16 | 4 | DeVore Susan D. — Director | Grant/award (A): 601 @ $0 | EDGAR |
Recent 8-K events — Elevance Health, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-10 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-10-21 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-10 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-07-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-10 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-05-13 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-22 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-10 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-03-02 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-02-26 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ELV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs